The global coronary atherectomy devices market is expected to grow at a compound annual growth rate (CAGR) of 6.03% from 2022 to 2028. Coronary atherectomy is a minimally invasive procedure used to remove plaque from the coronary arteries. Plaque is a build-up of fatty substances, cholesterol, and other materials that can narrow or block the arteries, reducing blood flow to the heart. This can lead to chest pain (angina), heart attack, and even death.

Coronary atherectomy is typically performed during a percutaneous coronary intervention (PCI), also known as an angioplasty or stent placement. During PCI, a thin catheter is inserted into the coronary artery through a small incision in the groin. The catheter is then guided to the site of the plaque build-up.

Discover Our Expert Analysis with Our Sample Report! https://bit.ly/49cwa3k

There are two main types of coronary atherectomy devices: directional and rotational. Directional atherectomy devices use a small blade to cut away the plaque. Rotational atherectomy devices use a rotating burr to grind away the plaque.

Coronary atherectomy devices are becoming increasingly popular as a treatment for coronary artery disease. This is due to the fact that they are minimally invasive and offer a number of advantages over other treatments, such as angioplasty and stent placement.

Future Outlook:

The global coronary atherectomy devices market is expected to continue to grow in the coming years. This growth will be driven by the increasing prevalence of coronary artery disease, the rising demand for minimally invasive procedures, and the favorable reimbursement scenario for atherectomy procedures.

The development of new and innovative atherectomy devices is also expected to contribute to the growth of the market. For example, some companies are developing atherectomy devices that can be used to treat calcified plaque, which is a difficult type of plaque to remove.

Overall, the outlook for the global coronary atherectomy devices market is positive. The market is expected to experience significant growth in the coming years, driven by a number of factors, including the increasing prevalence of coronary artery disease, the rising demand for minimally invasive procedures, and the favorable reimbursement scenario for atherectomy procedures.

Key Takeaways:

• The global coronary atherectomy devices market is expected to grow at a CAGR of 6.03% during the forecast period 2022-2028.
• The increasing prevalence of coronary artery disease (CAD) and the growing demand for minimally invasive procedures are the key drivers of the market growth.
• The rotational atherectomy segment is expected to account for the largest share of the market during the forecast period, owing to its wide acceptance and effectiveness in treating calcified plaque.
• The hospital segment is expected to remain the dominant end-user of coronary atherectomy devices during the forecast period.
• North America is expected to remain the largest market for coronary atherectomy devices throughout the forecast period.

Key Players:

• Medtronic
• Avinger
• Philips
• Boston Scientific
• Spectranetics
• Cardiovascular Systems
• ShockWave Medical
• Asahi Intecc
• EKOS Corporation
• Conor Medsystems
• Reva Medical
• Straub Medical

Segmentation:

By Type:

• Rotational Atherectomy Devices
• Directional Atherectomy Devices
• Laser Atherectomy Devices
• Orbital Atherectomy Devices
• Other Atherectomy Devices

By Application:

• Coronary Artery Disease
• Peripheral Artery Disease
• Renal Artery Disease
• Other Applications

By End-User:

• Hospitals
• Clinics
• Ambulatory Surgery Centers

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa